Seems odd that this was approved given an expert panel shot them down on meager benefits. Sometimes the FDA's decisions really make me scratch my head. Doubt this can really compete with Advair
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.